From Ozempic to recovery injections to anti-aging research — peptides are everywhere right now. If you’ve been curious but confused, this is where you start.
Great question — and a lot simpler than you’d think. Here’s the 60-second version.
A peptide is just a short chain of amino acids — the same building blocks that make up protein. The difference is size. Proteins are long and complex. Peptides are small, fast, and built to do one specific job.
You already know some of them. Insulin — the hormone that controls blood sugar — is a peptide. Oxytocin, the “bonding hormone,” is a peptide. The signals your body uses to heal a cut, regulate your hunger, or build collagen in your skin? All peptides. Your body makes thousands of them.
What researchers are excited about is the idea of synthetic peptides — lab-made versions that mimic or amplify what the body already does naturally. That’s what Ozempic is. That’s what BPC-157 is. That’s what this whole space is about.
From Ozempic to BPC-157 — these are the peptides showing up in research, in clinics, and in conversations. Tap any card to get the full story.
This is the part that surprises most people. Peptides aren’t random — they’re incredibly precise. Here’s how it works.
Some peptides are produced naturally — your body makes them all day long. Others are synthetic versions engineered to do the same job, but last longer and work more consistently.
Think of it like a key cut for one specific lock. Each peptide is shaped to bind to one type of receptor on one type of cell — and only that receptor. It has a destination.
When the peptide binds to its receptor, it triggers a chain reaction inside the cell — producing a protein, releasing a hormone, starting a repair process.
Tissue heals faster. Hunger decreases. Fat gets burned. Collagen gets built. The precision is the whole point.
Semaglutide, Tirzepatide, Ozempic, Wegovy — they’re all in this category. Here’s the actual science behind why a weekly shot can change how hungry you feel.
Peptide research isn’t one thing — it’s happening across five very different areas of health and performance. Here’s the breakdown.
A quick-reference guide to what each peptide is, what it’s being studied for, and where it stands with regulators.
| Peptide | Type | Primary Focus | Status |
|---|---|---|---|
| BPC-157 | Peptide fragment | Wound healing, GI protection, tendon repair | Preclinical |
| TB-500 | Thymosin β-4 fragment | Muscle repair, angiogenesis, inflammation | Preclinical |
| Epitalon | Tetrapeptide | Telomere elongation, aging, sleep | Research |
| MOTS-c | Mitochondrial peptide | Insulin sensitivity, metabolic regulation, aging | Research |
| GHK-Cu | Copper-binding tripeptide | Collagen synthesis, wound healing, antioxidant | Topical Use |
| CJC-1295 | GHRH analog | Growth hormone release, body composition | Research |
| Ipamorelin | GHS / Ghrelin mimetic | Selective GH secretion, body composition | Research |
| AOD-9604 | HGH fragment 176-191 | Fat metabolism, lipolysis, anti-obesity | Phase IIb |
| Tesamorelin | GHRH analog | Visceral fat reduction, HIV lipodystrophy | FDA Approved* |
| Retatrutide | Triple agonist | Obesity, metabolic syndrome, glucose control | Phase III |
| Tirzepatide | GLP-1/GIP dual agonist | Type 2 diabetes, obesity management | FDA Approved |
| Semaglutide | GLP-1 receptor agonist | Diabetes, weight management, CV risk | FDA Approved |
* Tesamorelin approved for HIV-associated lipodystrophy only. Research-stage peptides lack general clinical approval.